An international team of researchers has identified a protein that helps heart muscle cells regenerate after a heart attack. Researchers also showed that a patch loaded with the protein and placed inside the heart improved cardiac function and survival rates after a heart attack in mice and pigs.
Animal hearts regained close to normal function within four to eight weeks after treatment with the protein patch. It might be possible to test the patch in human clinical trials as early as 2017. The team, led by Professor Pilar Ruiz-Lozano at Stanford University and involving researchers from the University of California, San Diego and Sanford Burnham Prebys Medical Discovery Institute (SBP) published their findings in the Sept. 16 online issue of Nature.
“We are really excited about the prospect of bringing this technology to the clinic,” said Mark Mercola, professor of Bioengineering at UC San Diego and professor in the Development, Aging, and Regeneration Program at SBP. “It’s commercially viable, clinically attractive and you don’t need immunosuppressive drugs.”
High throughput technology in Mercola’s lab was critical in identifying a natural protein, called Follistatin-like 1 (FSTL1), and showing that it can stimulate cultured heart muscle cells to divide. Researchers led by Ruiz-Lozano at Stanford embedded the protein in a patch and applied it to the surface of mouse and pig hearts that had undergone an experimental form of myocardial infarction or “heart attack.” Remarkably, FSTL1 caused heart muscle cells already present within the heart to multiply and re-build the damaged heart and reduce scarring.
Heart muscle regeneration and scarring are two major issues that current treatments for heart attacks do not address, said Ruiz-Lozano. “Treatments don’t deal with this fundamental problem—and consequently many patients progressively lose heart function, leading to long-term disability and eventually death,” she said.
Today, most patients survive a heart attack immediately after it happens. But the organ is damaged and scarred, making it harder to pump blood. Sustained pressure causes scarring to spread and ultimately leads to heart failure. Heart failure is a major source of mortality worldwide, and roughly half of heart failure patients die within five to six years. Treatments available today focus primarily on making it easier for the heart to pump blood, and advances have extended patients’ lives. But they can’t help regenerate heart tissue.
The team initially looked to other species for inspiration. Lower vertebrates, such as fish, can regenerate heart muscle, and prior studies in fish suggested that the epicardium, the heart’s outside layer, might produce regenerative compounds. The researchers joined forces to find a solution.
The team started with the epicardial cells themselves, and showed that they stimulated existing heart muscle cells, or cardiomyocytes, to replicate. To find whether a single compound might be responsible, the Mercola lab used mass spectrometry, a sophisticated technology, to find over 300 proteins produced by the cells that could fit the bill. They then screened a number of these candidates using high throughput assays to look for the ones that had the same activity as the cells, and found that only one did the job: Follistatin-like 1 (FSTL1).
The Latest on: Protein patch
via Google News
The Latest on: Protein patch
- With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cashon June 26, 2020 at 3:07 pm
DBV Technologies still expects to receive an FDA decision in early August for its peanut allergy patch. But on Friday the company, which is headquartered ...
- DBV Technologies Provides Operational and Business Updateon June 25, 2020 at 11:30 pm
DBV Technologies Provides Operational and Business Update BLA review of Viaskin Peanut for the treatment of peanut allergy in children ages ...
- Neurotez: Can Leptin Prove Beneficial for Alzheimer's Patients?on June 24, 2020 at 7:03 am
PMN.TO Rethinking the approach to treat Alzheimer’s disease Both scientists and physicians are still wrestling with the idea of how to identify the biological drivers that are responsible for the ...
- What Is Psoriasis — Symptoms, Causes, Treatment Optionson June 22, 2020 at 5:37 pm
More than eight million people in the United States have the autoimmune skin condition known as psoriasis, according to the National Psoriasis Foundation. Psoriasis is a chronic condition. There’s no ...
- LTP of inhibition at PV interneuron output synapses requires developmental BMP signalingon June 22, 2020 at 2:23 am
To assess whether bone morphogenetic protein (BMP) signaling contributes to the developmental ... Here, we use genetic tools, patch-clamp recordings and single-cell gene expression analyses to address ...
- How to Fix a Broken Nail, According to the Expertson June 21, 2020 at 5:45 am
But show me an individual whose most pressing concern is a broken nail, and I'll show you a hand model who has no interpersonal relationships and never watches the news. That said, breaking a nail is ...
- This Baby Seal Safari Is the Reason You Have to Go To Canada Next Winteron June 20, 2020 at 5:56 am
It's the trip to Canada that just might beat Banff or the Northern Lights. Clad in bright orange survival suits, we tumble out of four helicopters and scramble across a patch of floating pack ice in ...
- Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030on June 18, 2020 at 1:22 am
Reportlinker.com announces the release of the report "Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030" -.
- Almeida's Vegetable Patch launching Almeida's Earth Bar food truckon June 12, 2020 at 8:16 am
Almeida’s Vegetable Patch typically has a sign visible on GAR ... spinach or kale-based ones and protein ones such as chocolate peanut butter. “I think that will be really popular,” Mello ...
- Potential COVID-19 vaccine could be applied in a patchon June 10, 2020 at 5:39 am
The drug would be administered to patients on a small patch the size of a postage stamp ... said they already knew to look for a particular protein called a spike protein.
via Bing News